Cite
Quantitative analysis of necrostatin-1, a necroptosis inhibitor by LC–MS/MS and the study of its pharmacokinetics and bioavailability.
MLA
Geng, Fang, et al. “Quantitative Analysis of Necrostatin-1, a Necroptosis Inhibitor by LC–MS/MS and the Study of Its Pharmacokinetics and Bioavailability.” Biomedicine & Pharmacotherapy, vol. 95, Nov. 2017, pp. 1479–85. EBSCOhost, https://doi.org/10.1016/j.biopha.2017.09.063.
APA
Geng, F., Yin, H., Li, Z., Li, Q., He, C., Wang, Z., & Yu, J. (2017). Quantitative analysis of necrostatin-1, a necroptosis inhibitor by LC–MS/MS and the study of its pharmacokinetics and bioavailability. Biomedicine & Pharmacotherapy, 95, 1479–1485. https://doi.org/10.1016/j.biopha.2017.09.063
Chicago
Geng, Fang, Hang Yin, Zhe Li, Qin Li, Chaoran He, Zheng Wang, and Junxian Yu. 2017. “Quantitative Analysis of Necrostatin-1, a Necroptosis Inhibitor by LC–MS/MS and the Study of Its Pharmacokinetics and Bioavailability.” Biomedicine & Pharmacotherapy 95 (November): 1479–85. doi:10.1016/j.biopha.2017.09.063.